COYA TAPIA to Follow-Up Studies
This is a "connection" page, showing publications COYA TAPIA has written about Follow-Up Studies.
Connection Strength
0.048
-
Phase 2 study of pembrolizumab in patients with advanced rare cancers. J Immunother Cancer. 2020 03; 8(1).
Score: 0.016
-
Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma. J Immunother Cancer. 2019 09 18; 7(1):253.
Score: 0.015
-
IMRT with ?8FDG-PET\CT based simultaneous integrated boost for treatment of nodal positive cervical cancer. Radiat Oncol. 2014 Mar 25; 9:83.
Score: 0.010
-
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer. J Clin Pathol. 2007 Jul; 60(7):768-72.
Score: 0.006